Facebook
X
LinkedIn
Forward| Session |
Date |
|---|---|
| BMT Research Updates | 04/01/2025 - 8:45am to 9:30am MDT |
| CD19x22 CAR T cell therapy and severe ICANS: it’s been a bumpy ride | 04/08/2025 - 8:45am to 9:30am MDT |
| BMT Quality Reporting: Clinical Chart Audit | 04/15/2025 - 8:45am to 9:30am MDT |
| BMT/CT Quality Reporting: Occurrences- Apheresis, Laboratory, Clinical | 04/22/2025 - 8:45am to 9:30am MDT |
| Establishing Multidisciplinary Frameworks for CMV Prevention and Treatment in High-Risk Posttransplant Patients | 04/29/2025 - 2:45am to 3:30am MDT |
| Journal Club: If You Can’t Beat Them, Engineer Them: The Rise of the CD7 CAR-T | 05/06/2025 - 8:45am to 9:30am MDT |
| GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity | 05/13/2025 - 8:45am to 9:30am MDT |
| Verneris: High-Risk AML COG Paper | 05/27/2025 - 8:45am to 9:30am MDT |
| BMT Quality Reporting: Clinical Annual Report | 06/03/2025 - 8:45am to 9:30am MDT |
| BMT Quality Reporting: Apheresis, BMTL Annual Report | 06/10/2025 - 8:45am to 9:30am MDT |